# Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer

> **NCT03949270** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 400 (actual)

## Conditions studied

- Breast Cancer
- Adherence, Medication
- Side Effect

## Interventions

- **BEHAVIORAL:** BETA-Text text messaging intervention

## Key facts

- **NCT ID:** NCT03949270
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-22
- **Primary completion:** 2023-04-21
- **Final completion:** 2023-11-01
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03949270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03949270, "Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03949270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*